(Subscription required) Plaintiffs behind a closely watched lawsuit challenging San Francisco's handling of homelessness, drug use and public-health policies in the Tenderloin have dismissed the case with prejudice after a federal judge ruled they lacked standing to pursue injunctive relief against the city.

The resentencing request stems from changes in California law over the past several years. Senate Bill 1437, which took effect Jan. 1, 2019, created a pathway for people convicted of murder to seek resentencing, but did not initially apply to attempted murder cases.

A decision could change product liability law ​if it effectively required drugmakers to spend more to develop and ​quickly commercialize alternative products, sometimes called a "duty to innovate." The case ⁠was brought by about 24,000 HIV patients who took Gilead drugs made with ​tenofovir disoproxil fumarate, or TDF.

“I think, at a very basic level, people think we’re making policy decisions, we’re saying we think this is how things should be, as opposed to what the law provides,” he said. “I think they view us as purely political actors, which I don’t think is an accurate understanding of what we do.”